“This Orphan Drug Designation from the USFDA underlines the urgent need to develop Usnoflast to address Amyotrophic Lateral Sclerosis (ALS), which is a fatal neurodegenerative disease," said Zydus' ...

The ALS Association this summer will host the second edition of its ALS Nexus, a conference bringing together researchers, healthcare professionals, advocates, patients, and caregivers in a quest to ...

A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...

MONTREAL — The Montreal Alouettes have locked in their veteran quarterback. The Als signed McLeod Bethel-Thompson for the 2025 season, the team announced on Monday. He was acquired in a trade ...

Alchemab Therapeutics has partnered with Eli Lilly to develop new antibody treatments for amyotrophic lateral sclerosis (ALS) based on an approach that looks at the immune response of those with ...

Dr. Richard Bedlack wears a studded leather jacket. Photo: Courtesy of Duke Health Smarter, faster on what matters.